Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SZSE:301033's Dividend Payout Ratio is ranked better than 57.09% of 282
companies
in the Medical Devices & Instruments industry
Industry Median: 0.42
vs SZSE:301033: 0.38
During the past 12 months, Medprin Regenerative Medical Technologies Co's average Dividends Per Share Growth Rate was 16.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 81.70% per year.
During the past 8 years, the highest 3-Year average Dividends Per Share Growth Rate of Medprin Regenerative Medical Technologies Co was 81.70% per year. The lowest was 81.70% per year. And the median was 81.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Medprin Regenerative Medical Technologies Co (SZSE:301033) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Medprin Regenerative Medical Technologies Co Dividend Payout Ratio Related Terms
Medprin Regenerative Medical Technologies Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medprin Regenerative Medical Technologies Co Dividend Payout Ratio Chart
Medprin Regenerative Medical Technologies Co Annual Data
SZSE:301033 vs ABT, SYK, MDT: Dividend Payout Ratio Comparison
For the Medical Devices subindustry, Medprin Regenerative Medical Technologies Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medprin Regenerative Medical Technologies Co Dividend Payout Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medprin Regenerative Medical Technologies Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Medprin Regenerative Medical Technologies Co's Dividend Payout Ratio falls into.
Medprin Regenerative Medical Technologies Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medprin Regenerative Medical Technologies Co (SZSE:301033) has a Dividend Payout Ratio of 0.00 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Medprin Regenerative Medical Technologies Co and its competitors. Over the past decade, Medprin Regenerative Medical Technologies Co's Dividend Payout Ratio has ranged from 0.28 to 0.39. According to the industry distribution chart, Medprin Regenerative Medical Technologies Co ranks #121 out of 282 companies in the Medical Devices & Instruments industry, placing it in the top 42.9%.
Is Medprin Regenerative Medical Technologies Co's Dividend Payout Ratio too high?
Medprin Regenerative Medical Technologies Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 0.39. Based on the distribution chart, Medprin Regenerative Medical Technologies Co ranks #121 out of 282 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medprin Regenerative Medical Technologies Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medprin Regenerative Medical Technologies Co's Dividend Payout Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medprin Regenerative Medical Technologies Co ranks #121 out of 282 companies for Dividend Payout Ratio. This puts Medprin Regenerative Medical Technologies Co in the upper half of its industry. The industry median Dividend Payout Ratio is 0.42. Historically, Medprin Regenerative Medical Technologies Co's own Dividend Payout Ratio has ranged from 0.28 to 0.39 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Devices & Instruments company?
The median Dividend Payout Ratio among Medical Devices & Instruments companies is 0.42, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Medprin Regenerative Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median Dividend Payout Ratio is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medprin Regenerative Medical Technologies Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medprin Regenerative Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co (SZSE:301033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥73.45, compared to a current price of ¥52.82 — trading 28.1% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Medprin Regenerative Medical Technologies Co's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Medprin Regenerative Medical Technologies Co (SZSE:301033), the current Dividend Payout Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medprin Regenerative Medical Technologies Co (SZSE:301033) Overvalued in 2026?
Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥52.82 is trading 28.1% below its estimated GF Value™ of ¥73.45.
GuruFocus considers Medprin Regenerative Medical Technologies Co to be Modestly Undervalued.
Key valuation signals for SZSE:301033:
Dividend Payout Ratio: 0.00
GF Value™: ¥73.45 vs. price of ¥52.82 (28.1% below fair value)
No single metric tells the full story. See the SZSE:301033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301033 has been successfully added to your 
